Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
(NASDAQ:SNGX),(NYSE:PFE),(NYSE:MRK),(NYSE:BMY),(NASDAQ:INSM), AUSTIN, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE) — BioMedWire: Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more than 30 million Americans are affected by rare diseases, according to the National Institutes of Health. The vast majority of these conditions […]